A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: Evidence from mice and humans

Cancer Research

Volumn 68, Issue 20, 2008, Pages 8419-8428

  Staquicini, Fernanda I ^a   Tandle, Anita ^b   Libutti, Steven K ^b   Sun, Jessica ^a   Zigler, Maya ^a   Bar Eli, Menashe ^a   Aliperti, Fabiana ^c   Pérez, Elizabeth C ^c   Gershenwald, Jeffrey E ^a   Mariano, Mario ^c   Pasqualini, Renata ^a   Arap, Wadih ^a   Lopes, José Daniel ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BIOCHEMISTRY; CELL INTERACTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VIVO STUDY; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR GROWTH; UPREGULATION;

ANIMALS; ANTIGENS, CD146; B-LYMPHOCYTE SUBSETS; CELL COMMUNICATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MELANOMA; MICE; PHOSPHORYLATION;

EID: 54249161032     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1242     Document Type: Article

References (41)

1. Prehn RT. Perspectives on oncogenesis: does immunity stimulate or inhibit neoplasia? J Reticuloendothel Soc 1971;10:1-16.
2. Prehn RT. The immune reaction as a stimulator of tumor growth. Science 1972;176:170-1.
3. Wexler H, Sindelar WF, Ketcham AS. The role of immune factors in the survival of circulating tumor cells. Cancer 1976;37:1701-6.
4. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
5. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005;7:411-23.
6. Fidler IJ. Molecular biology of cancer: invasion and metastasis In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Vol. 1. New York: Lippincott-Raven; 1997. p. 135-52.
7. Bartholomaeus WN, Bray AE, Papadimitriou JM, Keast D. Immune response to a transplantable malignant melanoma in mice. J Natl Cancer Inst 1974;53:1065-72.
8. Fidler IJ, Gersten DM. Effect of syngeneic lymphocytes on the vascularity, growth and induced metastasis of the B16 melanoma. In: Crispen RG, editor, Neoplasm immunity: experimental and clinical. Vol. 3. Amsterdam: Elsevier North Holland; 1980. p. 3-15.
9. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002;20:253-300.
10. Hardy RR, Hayakawa K. Development and physiology of Ly-1 B and its human homolog, Leu-1 B. Immunol Rev 1986;93:53-79.
11. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993;11:501-38.
12. Fagarasan S, Watanabe N, Honjo T. Generation, expansion, migration and activation of mouse B1 cells. Immunol Rev 2000;176:205-15.
13. Staquicini FI. B-1 lymphocytes modulate the metastatic potential of murine melanoma through a specific interaction mediated by MUC18 [dissertation]. São Paulo (Brazil): Federal University of São Paulo; 2004.
14. Pérez EC, Machado J, Jr., Aliperti F, Freymüller E, Mariano M, Lopes JD. B-1 lymphocytes increase metastatic behavior of melanoma cells through the extracellular signal-regulated kinase pathway. Cancer Sci 2008;99:920-8.
15. Almeida SR, Aroeira LS, Freymuller E, et al. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate. Int Immunol 2001;13:1193-201.
16. e Brito RR, De Lorenzo BH, Xander P, et al. Role of distinct immune components in the radiation-induced abrogation of systemic lupus erythematosus development in mice. Lupus 2007;16:947-54.
17. Popi AF, Lopes JD, Mariano M. Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro. Immunology 2004;113:348-54.
18. Giordano RJ, Cardó-Vila M, Lahdenranta J, Pasqualini R, Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat Med 2001;7:1249-53.
19. Pasqualini R, Koivunen E, Kain R, et al. Aminopeptidase Ni s a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000;60:722-7.
20. Cardó-Vila M, Arap W, Pasqualini R. αvβ5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V. Mol Cell 2003;11:1151-62.
21. Marchiò S, Lahdenranta J, Schlingemann RO, et al. Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 2004;5:151-62.
22. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med 2004;10:625-32.
23. Arap MA, Lahdenranta J, Mintz PJ, et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004;6:275-84.
24. Hajitou A, Trepel M, Lilley CE, et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 2006;125:385-98.
25. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996;380:364-6.
26. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003;77:8957-61.
27. Kantor AB. The development and repertoire of B-1 cells (CD5 B cells). Immunol Today 1991;12:389-91.
28. Khan WN, Alt FW, Gerstein RM, et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995;3:283-99.
29. Santos-Lima EC, Vasconcellos R, Reina-San-Martin B, et al. Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection. Eur J Immunol 2001;31:634-45.
30. Shih IM. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 1999;189:4-11.
31. Yang H, Wang S, Liu Z, et al. Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability. Gene 2001;265:133-45.
32. Jean D, Gershenwald JE, Huang S, et al. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem 1998;273:16501-8.
33. Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 1993;3:35-41.
34. + B-cell subset. Science 1987;236:77-81.
35. + B cells. Science 1987;236:81-3.
36. Gieni RS, Umetsu DT, DeKruyff RH. Ly1- (CD5-) B cells produce interleukin (IL)-10. Cell Immunol 1997;175:164-70.
37. McGary EC, Heimberger A, Mills L, et al. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clin Cancer Res 2003;9:6560-6.
38. McGary EC, Lev DC, Bar-Eli M. Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biol Ther 2002;1:459-65.
39. Mills L, Tellez C, Huang S, et al. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res 2002;62:5106-14.
40. Filshie RJ, Zannettino AC, Makrynikola V, et al. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia 1998;12:414-21.
41. Wu GJ, Fu P, Chiang CF, et al. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. J Urol 2005;173:1778-83.